Coolfinity Company Profile

Background

Overview

Coolfinity is a Dutch company specializing in the development and distribution of innovative refrigeration solutions designed to operate reliably in regions with unstable or limited power supply. Founded in 2016, the company focuses on providing medical-grade refrigerators that ensure the safe storage of vaccines, medications, and other biologicals, even during power outages. Their technology is particularly beneficial in tropical countries where power disruptions are common.

Mission and Vision

Coolfinity's mission is to prevent the spoilage of essential healthcare products by delivering reliable cooling solutions to areas with unreliable electricity. Their vision is a world where every community, regardless of its remoteness or fragile infrastructure, has access to safe and effective medicines.

Industry Significance

In many emerging markets, long power outages are a major daily problem, making reliable cooling essential. Coolfinity addresses this challenge by providing refrigerators that can maintain a stable temperature for up to 53 hours without electricity, thereby reducing vaccine waste and improving healthcare delivery in underserved regions.

Key Strategic Focus

Core Objectives

Reliable Cooling Solutions: Develop and provide refrigerators that maintain optimal temperatures for vaccines, medications, and biologicals during power outages.

Global Health Impact: Partner with international organizations to strengthen cold chain infrastructure and improve healthcare delivery in regions with unstable power supplies.

Areas of Specialization

Medical Refrigeration: Design and manufacture WHO-certified refrigerators tailored for medical and pharmaceutical applications.

Cold Chain Resilience: Enhance the reliability of cold chain systems in areas prone to power disruptions.

Key Technologies Utilized

Ice-Bank Thermal Battery: A patented technology that stores cooling energy and automatically activates during outages, maintaining a stable 2–8°C for up to 53 hours.

Active Air Circulation: Ensures even temperature distribution and humidity control to prevent condensation and spoilage.

Voltage Stabilizer & Surge Protection: Protects internal components from voltage spikes or power surges.

Primary Markets Targeted

Healthcare Providers: Hospitals, clinics, and pharmacies in regions with unreliable power grids.

International Organizations: Partnerships with entities like WHO, UNICEF, and GAVI to support global health initiatives.

Disaster Relief and Crisis Response: Deployment in areas affected by natural disasters or conflicts where power infrastructure is compromised.

Financials and Funding

Funding History

Coolfinity has secured funding from various investors, including Navus Ventures and the ACE Incubator - Sustainable Chemistry.

Total Funds Raised

Specific details regarding the total funds raised are not publicly disclosed.

Recent Funding Rounds

The company has participated in funding rounds, with notable investors such as Navus Ventures.

Notable Investors

Navus Ventures: An independent private investment fund.

ACE Incubator - Sustainable Chemistry: An incubator supporting sustainable chemistry innovations.

Intended Utilization of Capital

The raised capital is primarily utilized for product development, scaling operations, and expanding market reach to deliver reliable cooling solutions to underserved regions.

Pipeline Development

Key Pipeline Candidates

IceVolt 300 F and B: A large standing glass fridge designed to operate on weak grids or solar panels, capable of maintaining a stable temperature for 24 hours with only 4–6 hours of power.

IceVolt 300 Medical: A large standing glass pharmaceutical fridge that runs on weak grids, ensuring reliable cooling for medical applications.

IceVolt 140 Home: A tabletop standing fridge suitable for home use, designed to operate on weak grids or solar panels, maintaining a stable temperature for 24 hours with only 4–6 hours of power.

Stages of Development

These products are in the market deployment stage, with units already operational in various regions.

Target Conditions

The refrigerators are designed to maintain optimal temperatures for vaccines, medications, and biologicals during power outages, particularly in tropical climates.

Anticipated Milestones

Coolfinity continues to expand its product offerings and partnerships to enhance cold chain resilience globally.

Technological Platform and Innovation

Proprietary Technologies

Ice-Bank Thermal Battery: Stores cooling energy during power availability and releases it during outages, maintaining a stable temperature for extended periods.

Active Air Circulation: Ensures even temperature distribution and humidity control to prevent condensation and spoilage.

Voltage Stabilizer & Surge Protection: Protects internal components from voltage spikes or power surges.

Significant Scientific Methods

Thermal Energy Storage: Utilizing ice-bank technology to store and release cooling energy efficiently.

Humidity Control Systems: Maintaining optimal humidity levels to prevent condensation and ensure the safety of stored products.

Leadership Team

Key Executives

Maarten ten Houten: Founder and CEO. With 25 years of experience in sustainable innovation and marketing at Heineken and Philips, Maarten leads Coolfinity's mission to provide reliable cooling solutions.

Steven Burger: COO. Steven plays a pivotal role in operations, ensuring the efficient deployment and maintenance of Coolfinity's refrigeration units.

Leadership Changes

No significant leadership changes have been publicly reported.

Market and Competitor Profile

Market Insights and Dynamics

The global market for medical refrigeration solutions is expanding, driven by the increasing need for reliable cold chain infrastructure in regions with unstable power supplies. This growth is fueled by the rising demand for vaccines and medications in developing countries and the need for disaster preparedness.

Competitor Analysis

Porkka: A Finnish company specializing in commercial refrigeration solutions. While they offer a range of products, their focus is not specifically on medical-grade refrigerators for unstable power conditions.

Durabook: A rugged computing solutions provider that has trademarked "Coolfinity" for its fanless cooling design in laptops and tablets. This is a different application of the "Coolfinity" name and not directly related to Coolfinity's medical refrigeration focus.

Strategic Collaborations and Partnerships

UNICEF: Coolfinity has a three-year contract with UNICEF to supply medical refrigerators in 51 countries, making it one of seven suppliers for the organization.

Ukraine Partnership Facility (UPF): In partnership with UPF, Coolfinity delivered 600 refrigerators to health facilities across Ukraine to safeguard essential medicines during power disruptions.

Operational Insights

Coolfinity differentiates itself by offering WHO-certified refrigerators with a vertical glass door design, providing direct stock visibility without opening the unit and losing temperature. This design, combined with their patented ice-bank cooling technology, ensures reliable performance in challenging power conditions.

Strategic Opportunities and Future Directions

Coolfinity aims to expand its market presence by forming new partnerships with international organizations and governments to enhance cold chain resilience globally. The company is also exploring opportunities to integrate renewable energy sources, such as solar panels, into their refrigeration solutions to further improve sustainability.